Annovera - A New Contraceptive Vaginal Ring
Date: December 16, 2019
Issue #:
1587Summary: Annovera (TherapeuticsMD), a contraceptive vaginal
ring that releases segesterone acetate, a synthetic
progestin, and ethinyl estradiol, was approved by the
FDA in 2018 and is now available. It is the first product
to contain segesterone and the second vaginal ring
to become available in the US;NuvaRing, which
delivers etonogestrel and ethinyl estradiol, was the
first. UnlikeNuvaRing, which requires use of a new
ring each month, theAnnovera ring can be used for
an entire year, but it must be removed for one week
each month.
Source: The Medical Letter - Category: Drugs & Pharmacology Authors: admin Tags: Annovera Contraceptives Estrogens etonogestrel IUD Nexplanon NuvaRing ombitasvir paritaprevir Progestins Ritonavir segesterone Technivie Viekira Pak Source Type: research